Section of Family Planning and Contraceptive Research, Department of Obstetrics & Gynecology, University of Chicago, 5841 S. Maryland MC2050, Chicago, Illinois 60637, USA; Center for Interdisciplinary Inquiry and Innovation in Sexual and Reproductive Health (Ci3), University of Chicago, 6030 South Ellis Avenue, Chicago, Illinois 60637, USA.
Section of General Internal Medicine, Department of Medicine, University of Chicago, 5841 South Maryland MC6092, Chicago, IL 60637, USA.
Contraception. 2018 Oct;98(4):281-287. doi: 10.1016/j.contraception.2018.07.001. Epub 2018 Jul 10.
To evaluate the effect of miPlan, a waiting-room contraceptive counseling mobile application (app), on interest in discussing long-acting reversible contraception (LARC) during the clinical encounter and LARC uptake.
This randomized controlled trial evaluated the miPlan contraceptive counseling app. African American and Latina young women ages 15-29 years attending four family planning clinics in a large Midwestern city were randomized to either: (1) use miPlan (intervention) prior to the contraceptive clinic visit or (2) contraceptive clinic visit alone (control). Groups were compared on knowledge of contraceptive effectiveness, interest in discussing LARC, behavioral intentions to use LARC, and LARC uptake.
From February 2015 to January 2016, 207 young women were randomized to intervention (n=104) or control (n=103) group. Immediately following app use, the intervention group had an increase in knowledge and interest in learning about the implant. Immediate post visit, there was no significant difference in uptake of LARC between the two groups (p>.05). At three months post intervention, app users reported more knowledge of IUD effectiveness (52.3% vs 30.8%, p=.001) compared to controls. There was no significant difference in LARC use.
App use was not associated with an increase in using LARC methods. It was associated with increased knowledge of contraceptive effectiveness, an interest in learning about the implant, and behavioral intentions to use LARC methods.
The miPlan app is a feasible clinic adjunct for increasing contraceptive knowledge and intentions, however, it is not associated with increased LARC use. Mobile applications can offer an accessible complement to the contraceptive counseling visit.
评估 miPlan——一款候诊室避孕咨询移动应用程序（app）——对讨论长效可逆避孕（LARC）的临床兴趣和 LARC 使用率的影响。
本随机对照试验评估了 miPlan 避孕咨询应用程序。在中西部大城市的四家计划生育诊所就诊的年龄在 15-29 岁的非裔美国人和拉丁裔年轻女性被随机分为两组：（1）在避孕诊所就诊前使用 miPlan（干预组），或（2）仅避孕诊所就诊（对照组）。比较两组对避孕效果的了解、讨论 LARC 的兴趣、使用 LARC 的行为意向和 LARC 的使用率。
从 2015 年 2 月到 2016 年 1 月，共有 207 名年轻女性被随机分配到干预组（n=104）或对照组（n=103）。使用应用程序后，干预组对了解植入物的知识和兴趣增加。就诊后即刻，两组 LARC 的使用率没有显著差异（p>.05）。在干预后三个月，与对照组相比，应用程序使用者对 IUD 效果的了解有所增加（52.3%对 30.8%，p=.001）。LARC 的使用没有显著差异。
应用程序的使用与使用 LARC 方法的增加无关。它与增加避孕知识、对了解植入物的兴趣以及使用 LARC 方法的行为意向有关。
miPlan 应用程序是一种可行的诊所辅助手段，可增加避孕知识和意向，但与增加 LARC 使用无关。移动应用程序可以为避孕咨询访问提供一种易于获取的补充方式。
